Anrotinib Hydrochloride Combined With Adriamycin for Neoadjuvant Treatment of High-grade Soft Tissue Sarcoma

NCT05747521 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

85

Enrollment

OTHER_GOV

Sponsor class

Conditions

Soft Tissue Sarcoma

Interventions

DRUG: Anrotinib hydrochloride combined with adriamycin

Sponsor

Henan Cancer Hospital